Form 8-K - Current report:
SEC Accession No. 0001193125-26-010480
Filing Date
2026-01-12
Accepted
2026-01-12 16:34:50
Documents
16
Period of Report
2026-01-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d97670d8k.htm   iXBRL 8-K 68556
2 EX-99.1 d97670dex991.htm EX-99.1 53928
3 EX-99.2 d97670dex992.htm EX-99.2 23294
7 GRAPHIC g97670g0111114420980.jpg GRAPHIC 2466
8 GRAPHIC g97670g0111231102132.jpg GRAPHIC 2466
  Complete submission text file 0001193125-26-010480.txt   300084

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyme-20260106.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20260106_lab.xml EX-101.LAB 17992
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20260106_pre.xml EX-101.PRE 11263
18 EXTRACTED XBRL INSTANCE DOCUMENT d97670d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 26527217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)